[Effect of EG-1088, EG-626 and nifedipine on vascular lesions associated with hypertension and hyperlipidemia in stroke-prone spontaneously hypertensive rats (SHR-SP)].
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001158:Arteries / Q000187:drug effects*; D001488:Basilar Artery / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002536:Cerebral Arteries / Q000187:drug effects; D006949:Hyperlipidemias / Q000188:drug therapy / Q000503:physiopathology*; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D009543:Nifedipine / Q000008:administration & dosage / Q000494:pharmacology*; D010793:Phthalazines / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D011724:Pyridazines / Q000494:pharmacology*; D011799:Quinazolines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011918:Rats, Inbred SHR
D010793:Phthalazines; D010919:Placebos; D011724:Pyridazines; D011799:Quinazolines; C011329:phthalazinol; C038906:EG 1088; D009543:Nifedipine